Abstract
AbstractBiotechnology and the WTO have increasingly intersected following the growth of biotech trade. The regulatory challenge of biotechnology is a current subject of debate in the WTO. Biotechnology highlights emerging tensions between the effectiveness of the WTO law on biotech issues and the public health and the non-trade issues of biotech trade. Based on legal analysis, this paper reviews the policy issues caused by biotechnology and its implications on the organization and also considers the kind of policy options needed to achieve an appropriate balance between biotech interests and WTO discipline.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
